Title Cytokine biomarkers associated with clinical cases of acute flaccid myelitis.
Author Weldon, William C; Zhao, Kun; Jost, Heather A; Hetzler, Kimbell; Ciomperlik-Patton, Jessica; L Konopka-Anstadt, Jennifer; Steven Oberste, M
Journal J Clin Virol Publication Year/Month 2020-Oct
PMID 32836175 PMCID PMC9189760
Affiliation + expend 1.Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta GA, 30329, United States. Electronic address: wiw4@cdc.gov.

Acute flaccid myelitis (AFM) is a serious neurological illness first recognized in the United States in 2014, with subsequent outbreaks every two years. Following extensive etiologic testing by multiple laboratories of hundreds of specimens collected from patients diagnosed with AFM, no consistent cause of AFM has been identified. However, viruses, including enteroviruses, have been implicated through detection in non-sterile site specimens and antibody studies. Cytokines and chemokines play important roles in the modulation of the innate and adaptive immune response to pathogens. In the current study, we measured levels of cytokines and chemokines in serum and CSF collected from confirmed AFM patients and non-AFM control patients, to identify unique biomarkers as potential hallmarks of AFM pathogenesis. Analysis of ratios of cytokines and chemokines in the CSF compared to the serum indicate that the pro-inflammatory cytokines/chemokines IP-10 and IL-6 were significantly elevated in AFM patients compared to non-AFM patients. These results may provide additional insight into potential etiologies, pathogenic mechanisms, and treatments for AFM.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.